A new nanotheranostic based on azabodipy and nano graphene oxide: design and synthesis

Cancer is a group of diseases caused by uncontrolled proliferation of cells and its clinical appearance, diagnosis and treatment approaches are completely different processes. Current cancer treatments are surgery, chemotherapy and radiotherapy. In recent years, photodynamic and photothermal therapies have been very promising as new treatment modalities. Photodynamic therapy is widely used in the treatment of some non-cancerous or malignant diseases. This method of treatment is carried out by the use of a photosensitizer that selectively and effectively destroys diseased cells in the presence of a suitable light source, preferably in the near infrared region (650-800 nm). Although there have been many photosensitizers developed in recent years, a limited number of clinically approved therapeutic agents for real applications exists. Photothermal Therapy (FTT) is a treatment based on the conversion of absorbed near infrared (NIR) light into heat energy. FTT has also become very popular recently. In this thesis, synthesis and characterization of Aza BODIPY and reduced graphene oxide (rGO) based nanoteranostatic agent, namely AzaBODIPY®NrGO, were described. In vitro experiments have shown that this new nanomaterial can be used in both photodynamic therapy and photothermal therapy. It has been shown that AzaBODIPY®NrGO is a promising agent in the treatment of cancer.